fda decision on compounded tirzepatide confirms shortage is still over, gives compounders a grace period Important Notice: Tirzepatide Compounding Update

This dose will typically be continued for the first 4 weeks

Note: Patients titrated insulin glargine dose in a weekly manner and made the dose decision with the investigator for the first 8 weeks (phone or clinic visit)

Experiment within your first few weeks to find what works best for your body and schedule

The primary benefit of microdosing is a significant reduction in side effects like nausea, fatigue, and digestive upset

Additionally, integrating nutritional education could help patients adopt healthier eating habits that reinforce the medications benefits

Potential for Significant Side Effects: While not everyone experiences severe side effects, gastrointestinal symptoms can be pronounced for some individuals